Micronutrient Delivery Systems: Potential Health-Promoting Applications

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (20 February 2024) | Viewed by 2593

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada
Interests: microencapsulation; food fortification; food engineering

E-Mail Website
Guest Editor
Previously affiliated with the Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada
Interests: flavour processing; functional foods; microencapsulation; emulsification; food fortification; bioactive ingredients

E-Mail Website
Guest Editor
Department of Chemical and Biomedical Engineering, Division of Food, Nutrition and Exercise Sciences (Joint Appointment) University of Missouri, Columbia, MO 65211, USA
Interests: sustainable food systems engineering; upcycling food loss/waste to recover micronutrients; encapsulation (nano, micro, and macro); food fortification

Special Issue Information

Dear Colleagues,

Micronutrients are key components that play an important role in human body functioning, energy metabolism, and cell differentiation. They are considered vital ingredients contributing to the functionality of body organs, tissues, and the immune system. These components include trace minerals (e.g., iron, iodine, or zinc), macrominerals (e.g., calcium or phosphate), and vitamins (aqueous or fat-soluble). The deficiency of micronutrients in the human body due to their low intake and bioavailability can have a profound impact on human health and cause diseases including, but not limited to, anaemia, cancer, scurvy, and rickets. The uptake and bioavailability of micronutrients can be enhanced through encapsulation techniques and engineered delivery systems.

Delivery systems such as microspheres or micro/nanoparticles constructed from biodegradable polymers have been applied for the delivery of micronutrients. Colloidal systems including micelles, micro/nanoemulsions, Pickering emulsions, self-micro/nano-emulsifying drug delivery systems (SMEDDS/SNEDDS), liposomes, hydrogels, and solid-lipid micro/nanoparticles (SLMs/SLNs) have emerged recently as the potential delivery systems of micronutrients in drugs, vaccines, and fortified foods, and have proved to be effective in enhancing the intake and, simultaneously, the in vitro bioaccessibility or in vivo bioavailability of micronutrients. Moreover, inclusion complexes of micronutrients with natural or modified-type cyclodextrins are potential delivery systems that have been receiving specific attention in the food and pharmaceutical industries. These formulated delivery systems can enhance the targeted delivery and permeation of micronutrients administered through different routes (e.g., oral, intravenous/intramuscular, transdermal, intranasal, or ocular delivery) while enhancing their therapeutic effect through controlled release.

In light of the above, this Special Issue aims to focus on research or review articles to highlight recent advancements in the development of micronutrient delivery systems, emphasizing their applications in the development of drugs, vaccines, or fortified foods with enhanced health properties for ameliorating a patient’s health condition or treating diseases caused by micronutrient deficiency.

Prof. Dr. Levente L. Diosady
Dr. Shima Saffarionpour
Dr. Kiruba Krishnaswamy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • micronutrients
  • delivery systems
  • colloids
  • cyclodextrin inclusion complexes
  • in vitro bioaccessibility
  • in vivo bioavailability
  • targeted delivery
  • controlled release
  • fortified foods
  • drug development
  • therapeutic applications

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 1576 KiB  
Communication
Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs
by Anubhav Pratap-Singh, Yigong Guo, Alberto Baldelli and Anika Singh
Pharmaceutics 2023, 15(9), 2265; https://doi.org/10.3390/pharmaceutics15092265 - 1 Sep 2023
Cited by 4 | Viewed by 2021
Abstract
Injectable peptides such as insulin, glucagon-like peptide 1 (GLP-1), and their agonists are being increasingly used for the treatment of diabetes. Currently, the most common route of administration is injection, which is linked to patient discomfort as well as being subjected to refrigerated [...] Read more.
Injectable peptides such as insulin, glucagon-like peptide 1 (GLP-1), and their agonists are being increasingly used for the treatment of diabetes. Currently, the most common route of administration is injection, which is linked to patient discomfort as well as being subjected to refrigerated storage and the requirement for efficient supply chain logistics. Buccal and sublingual routes are recognized as valid alternatives due to their high accessibility and easy administration. However, there can be several challenges, such as peptide selection, drug encapsulation, and delivery system design, which are linked to the enhancement of drug efficacy and efficiency. By using hydrophobic polymers that do not dissolve in saliva, and by using neutral or positively charged nanoparticles that show better adhesion to the negative charges generated by the sialic acid in the mucus, researchers have attempted to improve drug efficiency and efficacy in buccal delivery. Furthermore, unidirectional films and tablets seem to show the highest bioavailability as compared to sprays and other buccal delivery vehicles. This advantageous attribute can be attributed to their capability to mitigate the impact of saliva and inadvertent gastrointestinal enzymatic digestion, thereby minimizing drug loss. This is especially pertinent as these formulations ensure a more directed drug delivery trajectory, leading to heightened therapeutic outcomes. This communication describes the current state of the art with respect to the creation of nanoparticles containing peptides such as insulin, glucagon-like peptide 1 (GLP-1), and their agonists, and theorizes the production of mucoadhesive unidirectional release buccal tablets or films. Such an approach is more patient-friendly and can improve the lives of millions of diabetics around the world; in addition, these shelf-stable formulations ena a more environmentally friendly and sustainable supply chain network. Full article
Show Figures

Figure 1

Back to TopTop